Lesson 7: Retinopathy of Prematurity
Retinopathy of Prematurity (ROP)
ROP causes abnormal vascular development in the retina, leading to risks of vasoconstriction, hemorrhage, and potential retinal detachment and blindness.
Key Risk Factors:
Prematurity
Hyperoxia
Management of Oxygen:
Minimize supplemental oxygen before retinal maturation (up to 44 weeks post-conception).
Maintain SpO2 levels between 89% - 94%, preferably monitored preductally (RUE).
Pathophysiology
Vasculogenesis Timeline:
Begins at week 16 and continues to week 44 post-conception, starting at the macula and spreading outward.
ROP Phases:
Phase 1: Inhibited growth of retinal vessels
Phase 2: Overgrowth of abnormal vessels with potential for retinal detachment.
Normal PaO2 Values:
In utero: 20 - 30 mmHg
After delivery: 55 - 85 mmHg
Higher PaO2 in premature neonates may lead to hyperoxia, disrupting normal vascular growth and leading to complications including retinal detachment.
Incidence and Risk Factors
ROP incidence inversely proportional to post-conceptual age and birth weight; affects up to 70% of infants weighing <1000 g at birth.
Most Significant Risk Factor: Prematurity
Modifiable Risk Factors: Hyperoxia (controllable oxygen administration).
Additional Risk Factors:
Mechanical ventilation
Blood transfusion
Intraventricular hemorrhage
Sepsis
Vitamin E deficiency
Anesthetic Management
Continue to monitor SpO2 and maintain levels carefully until retinal maturation is achieved.
Surgical options for late-stage ROP include:
Cryotherapy
Laser therapy
Scleral buckle
Vitrectomy